Publications by authors named "N Paillocher"
Objective: The aim of this study was to explore the feasibility and safety of the laparoscopic approach after neoadjuvant chemotherapy among selected chemosensitive patients with advanced ovarian cancer.
Methods: The CILOVE study was a phase II prospective non-randomized multicenter study. It aimed to enroll 47 women with unresectable disease at the time of initial diagnosis (International Federation of Gynecology and Obstetrics (FIGO) stage IV and/or diffuse extensive carcinomatosis for advanced FIGO stage IIIC or patients unfit to withstand radical primary surgery), in response to chemotherapy and fit to undergo laparoscopy.
Article Synopsis
- The GANEA2 study focused on evaluating the accuracy and safety of sentinel lymph node (SLN) procedures in breast cancer patients who underwent neo-adjuvant chemotherapy (NAC).
- The study included patients categorized into two groups based on their lymph node status before treatment, with a main goal of determining the SLN false negative rate and other factors influencing patient outcomes.
- Results indicated a low false negative rate and suggested that patients without initial node involvement could safely skip axillary lymph node dissection if they had negative SLNs following NAC, while specific predictors could identify low-risk patients among those with initial node involvement.
Introduction: Most cancer patients require a totally implanted central venous catheter (TIVAD) for their treatment. In a previous study, we developed and validated a questionnaire dubbed QASICC (Questionnaire for Acceptance of, and Satisfaction with, Implanted Central Venous Catheter) assessing patient satisfaction with, and acceptance of, their TIVAD. In the present study, we conducted a large, prospective, multicenter study in cancer patients aimed to analyze factors that could influence patients' acceptance of, and satisfaction with, their device.
View Article and Find Full Text PDFObjectives: This study describes the outcomes of patients with colorectal peritoneal carcinomatosis (PC) with or without liver metastases (LMs) after curative surgery combined with hyperthermic intraperitoneal chemotherapy, in order to assess prognostic factors.
Background: Cytoreductive surgery (CRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) increases overall survival (OS) in patients with PC. The optimal treatment both for PC and for LMs within one surgical operation remains controversial.